Biomarkers of intestinal permeability are associated with inflammation in metabolically healthy obesity but not normal-weight obesity

被引:0
|
作者
Keirns, Bryant H. [1 ]
Medlin, Austin R. [2 ]
Maki, Katherine A. [3 ]
McClanahan, Kristen [4 ]
Fruit, Sarah E. [1 ]
Sciarrillo, Christina M. [4 ]
Hart, Samantha M. [4 ]
Joyce, Jill [4 ]
Lucas, Edralin A. [4 ]
Emerson, Sam R. [4 ]
机构
[1] Ball State Univ, Dept Nutr & Hlth Sci, Muncie, IN 47306 USA
[2] Indiana Univ, Sch Publ Hlth, Dept Hlth & Wellness Design, Bloomington, IN USA
[3] NIH, Translat Biobehav & Hlth Dispar Branch, Clin Ctr, Bethesda, MD USA
[4] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2024年 / 327卷 / 05期
关键词
cardiovascular disease; gut permeability; inflammation; metabolically healthy obesity; normal-weight obesity; INSULIN-RESISTANCE; OXIDATIVE STRESS; GUT PERMEABILITY; EATING INDEX; SERUM-LEVELS; INDIVIDUALS; MARKERS; ENDOTOXEMIA; DYSFUNCTION; MORTALITY;
D O I
10.1152/ajpheart.00381.2024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic inflammation is reported in normal-weight obesity (NWO) and metabolically healthy obesity (MHO), which may be linked to their increased cardiovascular disease (CVD) risk. Yet, drivers of this inflammation remain unclear. We characterized factors known to influence inflammatory status (i.e., intestinal permeability, adipose tissue, diet quality, microbiota), and their relationships with measured inflammation, in NWO and MHO, healthy control subjects (CON), and metabolically unhealthy obesity (MUO; N = 80; n = 20/group). Serum indicators of intestinal permeability and inflammation were assessed by ELISA and/or multiplex. Total, visceral, and percent body fat were measured with dual-energy X-ray absorptiometry (DXA). Fecal microbiota composition was assessed via 16S rRNA sequencing (n = 9-10/group). For C-reactive protein (CRP), MUO > NWO > CON (P < 0.0001). In MHO, CRP was intermediate and similar to both MUO and NWO. Lipopolysaccharide binding protein (LBP) and the ratio of LBP to soluble CD14 (sCD14) were higher in MHO and MUO vs. CON/NWO (P < 0.0001). Across correlation and regression analyses, LBP consistently displayed the strongest relationships with CRP in the entire sample (r = 0.78; beta = 0.57; P < 0.0001) and in MHO (r = 0.74; P < 0.01) but not NWO (r = 0.37; P = 0.11). Shannon index was higher in CON compared with MUO (P < 0.05) and inversely correlated with CRP in the full sample (r = -0.37; P < 0.05). These data are consistent with the notion that intestinal permeability is associated with low-grade inflammation in MHO, which could be implicated in this population's reported CVD risk. NEW & NOTEWORTHY This is the first study to our knowledge to examine biomarkers of intestinal permeability in normal-weight obesity and one of few assessing microbiota compositions in this population. Additionally, we report that individuals with metabolically healthy obesity and metabolically unhealthy obesity displayed similar evidence of intestinal permeability, which was more strongly associated with systemic inflammation than total and visceral adipose tissue mass.
引用
收藏
页码:H1135 / H1145
页数:11
相关论文
共 50 条
  • [1] Cardiorespiratory fitness and submaximal exercise dynamics in normal-weight obesity and metabolically healthy obesity
    Hart, Samantha M.
    Keirns, Bryant H.
    Sciarrillo, Christina M.
    Malin, Steven K.
    Kurti, Stephanie P.
    Emerson, Sam R.
    EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2024, 124 (04) : 1131 - 1142
  • [2] Cardiorespiratory fitness and submaximal exercise dynamics in normal-weight obesity and metabolically healthy obesity
    Samantha M. Hart
    Bryant H. Keirns
    Christina M. Sciarrillo
    Steven K. Malin
    Stephanie P. Kurti
    Sam R. Emerson
    European Journal of Applied Physiology, 2024, 124 : 1131 - 1142
  • [3] Evidence of genetic predisposition for metabolically healthy obesity and metabolically obese normal weight
    Huang, Lam O.
    Loos, Ruth J. F.
    Kilpelainen, Tuomas O.
    PHYSIOLOGICAL GENOMICS, 2018, 50 (03) : 169 - 178
  • [4] Phenotyping obesity: A focus on metabolically healthy obesity and metabolically unhealthy normal weight
    Agius, Rachel
    Pace, Nikolai P.
    Fava, Stephen
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2024, 40 (02)
  • [5] Dietary and Biochemical Characteristics Associated with Normal-Weight Obesity
    Amani, Reza
    Parohan, Mohammad
    Jomehzadeh, Nabi
    Haghighizadeh, Mohammad Hossein
    INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2019, 89 (5-6) : 331 - 336
  • [6] Metabolically Healthy and Unhealthy Normal Weight and Obesity
    Stefan, Norbert
    ENDOCRINOLOGY AND METABOLISM, 2020, 35 (03) : 487 - 493
  • [7] Metabolically healthy obesity and metabolically obese normal weight: a review
    Gomez-Zorita, Saioa
    Queralt, Maite
    Vicente, Maria Angeles
    Gonzalez, Marcela
    Portillo, Maria P.
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2021, 77 (01) : 175 - 189
  • [8] UPDATING THE CONCEPT OF METABOLICALLY HEALTHY OBESITY
    Bala, C.
    Craciun, A-E.
    Hancu, N.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2016, 12 (02) : 197 - 205
  • [9] Factors of Obesity and Metabolically Healthy Obesity in Asia
    Mathis, Bryan J.
    Tanaka, Kiyoji
    Hiramatsu, Yuji
    MEDICINA-LITHUANIA, 2022, 58 (09):
  • [10] Does Metabolically Healthy Obesity Exist?
    Munoz-Garach, Araceli
    Cornejo-Pareja, Isabel
    Tinahones, Francisco J.
    NUTRIENTS, 2016, 8 (06)